Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Acute Inflammation III: Local and Systemic Effects

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...

Bacterial Meningitis II: Pathophysiology

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...

Determinants of Bacterial Pathogenicity and Virulence

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...

Acute Pancreatitis II: Pathophysiology

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...

Infection

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...

Urinary Tract Infection II: Pathophysiology

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

<i>Mycobacterium tuberculosis</i> subverts macrophage-mediated defense through exploitation of the Zn transporter ZIP8.

iScience·2026

Same author

Lung microbiome predictors of epigenetic aging and potential associations with smoking and electronic cigarette use.

Clinical epigenetics·2026

Same author

Differences in influenza vaccine effectiveness by sex among adults hospitalized with acute respiratory illness-IVY network, January 24, 2022-September 1, 2024.

Vaccine·2026

Same author

The Role of Calibration Practices in Optimizing Continuous Glucose Monitor Accuracy in Critically Ill Patients.

CHEST critical care·2025

Same author

What's the connection? Sarcoidosis and combined variable immunodeficiency: A Single center retrospective case series.

Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG·2025

Same author

Genetics and Social Determinants of Health as Drivers of Epidemiologic Variation in Sarcoidosis.

Seminars in respiratory and critical care medicine·2025

Search research articles

Related Experiment Video

Updated: Jul 2, 2026

A Data-Driven Approach to Quantifying Immune States in Sepsis

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

Sepsis: links between pathogen sensing and organ damage.

Elliott Crouser¹, Matthew Exline, Daren Knoell

¹Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210, USA. crouser-1@medctr.osu.edu

Current Pharmaceutical Design

|August 12, 2008

Summary

Sepsis involves two inflammatory phases; new therapies targeting pathogen recognition receptors and mitochondrial function offer hope for managing sepsis and multiple organ dysfunction syndrome (MODS). Nutritional status also plays a key role in modulating sepsis outcomes.

More Related Videos

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats

Published on: February 20, 2021

Characterizing Salmonella Typhimurium-induced Septic Peritonitis in Mice

Characterizing Salmonella Typhimurium-induced Septic Peritonitis in Mice

Published on: July 29, 2022

Related Experiment Videos

Last Updated: Jul 2, 2026

A Data-Driven Approach to Quantifying Immune States in Sepsis

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats

Published on: February 20, 2021

Characterizing Salmonella Typhimurium-induced Septic Peritonitis in Mice

Characterizing Salmonella Typhimurium-induced Septic Peritonitis in Mice

Published on: July 29, 2022

Area of Science:

Immunology
Cellular Biology
Critical Care Medicine

Background:

Sepsis triggers a biphasic inflammatory response, involving innate immunity and leading to multiple organ dysfunction syndrome (MODS).
Cellular damage and death in MODS are significantly influenced by mitochondrial dysfunction.
Nutritional status and micronutrients impact inflammatory responses and organ failure susceptibility in sepsis.

Purpose of the Study:

To explore novel therapeutic strategies for sepsis by targeting pathogen recognition receptors (PRRs) and improving mitochondrial function.
To investigate the role of mitochondrial viability and cellular energy reserves in sepsis-induced cell death.
To examine the influence of nutritional status and micronutrients on sepsis progression and treatment.

Main Methods:

Review of current understanding of sepsis pathophysiology, focusing on inflammatory phases and cellular mechanisms.
Analysis of therapeutic targets including pathogen recognition receptors (TLRs, NOD-like receptors) and mitochondrial biogenesis.
Consideration of the impact of nutritional interventions and micronutrient repletion (e.g., zinc) on sepsis management.

Main Results:

Pathogen recognition receptors (PRRs) present therapeutic opportunities for modulating early and late sepsis inflammation.
Mitochondrial dysfunction is a key driver of cell death (apoptosis, necrosis) and inflammation in sepsis.
Interventions promoting mitochondrial biogenesis (e.g., insulin) and micronutrient repletion may improve sepsis outcomes.

Conclusions:

Targeting PRRs and enhancing mitochondrial viability are promising avenues for future sepsis therapies.
Addressing cellular energy deficits and inflammation through interventions like insulin and micronutrients could improve host survival.
Integrated therapeutic approaches combining immunomodulation, metabolic support, and nutritional optimization are crucial for effective sepsis management.